Caris QuantumAI RUO Report
A Quantum Leap in Molecular Intelligence
Caris QuantumAI™ is an innovative research-use-only (RUO) tumor profiling report that builds on the comprehensive foundation of the Caris Molecular Profiling Report to offer even deeper insights into tumor biology. Caris QuantumAI enhances the industry-leading capabilities of the standard Caris report, presenting cutting-edge data from Caris molecular profiling in more insightful ways to build the complete molecular blueprint of a patient’s cancer.
Tailored Insights for Every Tumor
The QuantumAI report embodies the future of precision oncology. Data from Caris’ AI-enhanced comprehensive molecular profiling is displayed in innovative, easy-to-interpret modular graphs and tables. In addition to pan-tumor reporting modules, QuantumAI also features tumor-specific options from its extensive menu.
Visualization Tools for Molecular Data
Pan-Tumor Report Modules Include:
- Next Generation Sequencing (NGS) Metrics
- Tumor Mutational Burden (TMB) Variants
- Enhanced eKaryotype
- Exon-Level Copy Number Alterations
- Relative RNA Expression Heatmap
- Visualization of RNA Fusions
- Immune Cell Deconvolution
Visualization of RNA fusions detected using whole transcriptome sequencing
When Every Insight Counts
Available upon request, Caris QuantumAI is a powerful tool for molecular tumor boards, case consults, and clinical trial decision-making. The AI-driven insights provided by QuantumAI can also be leveraged to confirm diagnoses and examine specific genomic features, such as fusions and molecular signatures.
Have Questions?
"*" indicates required fields
Discover
More
Caris is actively delivering on the promise of precision medicine and our pipeline reflects our future tests and molecular science-based solutions to help patients and improve the human condition.
Caris Life Sciences contributes to the body of research in oncology to advance the understanding of molecular science and further enable the delivery of precision medicine.